文献速递瓣膜外科

二尖瓣手术中的性别差异:倾向性评分匹配分析

The Silent Cost of Gender in Mitral Valve Surgery: A Propensity-Score Matched Analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2026-01-01

该回顾性研究纳入1531例接受二尖瓣手术(伴或不伴三尖瓣手术)的患者,比较性别差异。女性患者年龄更大、症状更重、瓣环钙化和三尖瓣病变更多,Carpentier IIIa型更常见,微创手术和修复率更低,30天和5年死亡率更高。校正形态和钙化后,性别不再是修复率或长期死亡率的独立预测因素。

要点

  • 女性二尖瓣手术患者就诊更晚、病变更复杂,修复率和微创手术率更低。
  • 女性30天死亡率(HR 4.07)和5年死亡率(HR 1.58)显著高于男性。
  • 校正瓣膜形态和钙化后,性别不再是修复率或长期死亡率的独立预测因素。

核心结论

  • 女性就诊时疾病分期更晚、二尖瓣病理更复杂,导致修复率和微创手术率更低、围术期死亡率更高。
  • 这些差异很大程度上归因于疾病形态而非性别本身。
  • 早期转诊女性患者对改善结局至关重要。

研究设计与样本

  • 回顾性分析1531例连续接受二尖瓣手术(伴或不伴三尖瓣手术)的患者。
  • 比较性别间基线特征、手术策略和结局,并使用倾向性评分匹配校正基线差异。
  • 主要结局为30天和5年死亡率。

主要发现

  • 女性占44%,年龄更大(68 vs 62岁,P < .001),NYHA III级更多(60% vs 46%,P < .001)。
  • 女性瓣环钙化(15% vs 5%,P < .001)和合并三尖瓣病变(25% vs 36%,P < .001)更常见。
  • 女性Carpentier IIIa型更常见(21% vs 4%),男性II型更常见(75% vs 49%)。
  • 女性微创二尖瓣手术率更低(49% vs 65%),修复率更低(67% vs 85%),两者P < .001。
  • 女性30天死亡率更高(HR 4.07,95% CI 1.51-11.0;P = .006),5年死亡率更高(HR 1.58,95% CI 1.02-2.46;P = .043)。

关键数值与推荐

  • 校正形态和钙化后,性别不再独立预测修复率或长期死亡率。

临床怎么用

  • 对女性二尖瓣疾病患者应考虑更早转诊,以避免延误至复杂病变阶段。
  • 在评估修复可能性和手术方式时,应充分考虑瓣膜形态和钙化等病变特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Mitral valve (MV) disease shows sex-specific differences in morphology and outcomes. Women often present later, undergo replacement more frequently, and experience worse survival. This study investigated sex-related disparities in surgical approach, repair rates, and outcomes of MV surgery. METHODS: A total of 1531 consecutive patients undergoing MV surgery with or without concomitant tricuspid valve procedure were analysed retrospectively. Baseline characteristics, operative strategies, and outcomes were compared between sexes. Propensity score matching was used to adjust for baseline differences. Primary outcomes were 30-day and 5-year mortality. Baseline and procedural characteristics, including morphology, repair rates, use of minimally invasive MV surgery (MIMVS), and concomitant tricuspid disease, were compared between groups. RESULTS: Female patients (44%) were older (68 vs 62 years, P < .001), more symptomatic (New York Heart Association [NYHA] III: 60% vs 46%, P < .001), and more likely to have annular calcification (15% vs 5%, P < .001) or concomitant tricuspid disease (25% vs 36%, P < .001). Carpentier type IIIa was more prevalent in women (21% vs 4%), while type II predominated in men (75% vs 49%). MIMVS and repair were less frequent in women (49% vs 65% and 67% vs 85%, both P < .001). Female sex was associated with increased 30-day (HR 4.07, 95% CI 1.51-11.0; P = .006) and 5-year mortality (HR 1.58, 1.02-2.46; P = .043). After adjusting for morphology and calcification, sex was no longer an independent predictor of repair rates or long-term mortality. CONCLUSIONS: Women present at a later stage of the disease and with more complex MV pathology, resulting in lower repair and MIMVS rates and higher perioperative mortality. These disparities are largely attributable to disease morphology rather than sex per se. Earlier referral of women is essential to improve outcomes.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Pölzl L, Lohmann R, Engler C, et al. The Silent Cost of Gender in Mitral Valve Surgery: A Propensity-Score Matched Analysis. Eur J Cardiothorac Surg. 2026. PMID: 41392323. doi:10.1093/ejcts/ezaf451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。